NCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
- State
- Under way
- Phase
- Phase 3
- People
- 20,080 taking part
- Started
- 5 Mar 2024
- Primary completion
- Apr 2028
- Arms
- Participants receiving placebo
- Results
- None posted
- 2 Oct 2023: Trial registered
- 5 Mar 2024: Trial started